Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease
Completed
- Conditions
- Dupuytren Contracture
- Registration Number
- NCT03331926
- Lead Sponsor
- Jeppe Lange
- Brief Summary
To evaluate the effect of collagenase clostridium histolyticum treatment at the Department of Orthopaedic surgery at Horsens Regional Hospital after minimum one-year follow-up (FU).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 199
Inclusion Criteria
- dupuytrens disease
- xiapex treatment
Exclusion Criteria
- demens/other psychiatric diseases
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in extension deficit from baseline to FU in MCP and PIP joints after treatment Minimum one year after treatment
- Secondary Outcome Measures
Name Time Method